Pharmafile Logo
Pharmafocus logo
Advanced Search

Manufacturing and Production

Showing 15 posts of 5860 posts found.

Tjaopack announces completion of Netherlands facility expansion

April 12, 2022 Manufacturing and Production

Tjaopack has announced the completion of its expansion plans, following a €10 million plus investment, at its Etten-Leur facility in …
News

Amid growing fears of antimicrobial-resistance, NHS payment scheme aims for pharma to tackle superbugs

April 12, 2022 Manufacturing and Production

NICE has shared that cefiderocol, and ceftazidime/avibactam, have the potential to save lives. The two medications, which fight drug-resistant superbugs, …
News

VR solution for personalised treatment and surgery guidance to spine surgeons

April 12, 2022 Manufacturing and Production

Seymourpowell and Axis Spine Technologies have announced a virtual reality (VR) solution allowing surgeons to evaluate and develop spinal implants …
News
shutterstock_187433765_16

European Commission approves treatment of unresectable uveal melanoma

April 5, 2022 Manufacturing and Production

Immunocore Holdings has announced that the European Commission has approved KIMMTRAK® (tebentafusp) for the treatment of HLA-A*02:01-positive adult patients with …
News

Technology enabling thermally-controlled DNA synthesis

April 5, 2022 Manufacturing and Production

Evonetix has been granted a patent in Europe for thermal control technology for DNA synthesis, as well as the design …
News

NHS struggling to make progress on early cancer diagnosis

April 5, 2022 Manufacturing and Production

MPs have warned that the NHS in England is struggling to make progress on its flagship target to diagnose three-quarters …
News

FDA approves generic version of brain imaging agent in US

April 5, 2022 Manufacturing and Production

The FDA has approved the generic version of DaTscan (Ioflupane I 123), manufactured and commercialised by Curium. This is a …
News
leipzig_skyline

FlyPharma Conference Europe: New dates and location announced

April 4, 2022 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

FlyPharma Conferences are pleased to announce that FlyPharma Europe is returning as a live, in-person event in 2022.
News

CHMP recommends approval of Janssen’s first CAR-T therapy

March 29, 2022 Manufacturing and Production

Johnson & Johnson have announced the CHMP recommendation of marketing authorisation of ciltacabtagene autoleucel (cilta-cel) for the treatment of adults …
News

Telix granted FDA orphan drug designation for bone marrow conditioning treatment

March 29, 2022 Manufacturing and Production

The FDA has granted Orphan Drug Designation (ODD) for TLX66, for conditioning treatment prior to hematopoietic stem cell transplant (HSCT). …
News

Japan: drug approved for treatment of life-threatening bleeding

March 29, 2022 Manufacturing and Production

AstraZeneca has announced that Ondexxya has become the first approved medicine in Japan to reverse the anticoagulant effect of Factor …
News

BIMZELX effective for moderate to severe plaque psoriasis treatment

March 29, 2022 Manufacturing and Production

UCB has revealed results from its Phase III/IIIb trials of BIMZELX (bimekizumab) for the treatment of adults with moderate to …
News

FDA approval for first drug for rare form of epilepsy

March 22, 2022 Manufacturing and Production

Those living in the US with CDKL5 deficiency disorder, or CDD, may now have access to the first FDA-approved treatment …
News

MDMA improves PTSD symptoms, study finds

March 22, 2022 Manufacturing and Production

In findings presented at the American Chemical Society’s (ACS) Spring Meeting for 2022, researchers reported on follow-up results form a …
News

Pfizer recalls blood pressure drug due to potential carcinogen

March 22, 2022 Manufacturing and Production

Pfizer is voluntarily recalling certain hypertension medications due to the potential presence of impurities. The affected products have been distributed …
News
The Gateway to Local Adoption Series

Latest content

Siemens Healthineers opens 10m euro R&D centre for laboratory equipment in Ireland

February 19, 2026

Everdrone announces new board of directors to drive expansion

February 19, 2026

Regeneron announces presentations of new data on Eylea HD for retinal disease

February 18, 2026

Indegene completes acquisition of Cake Health

February 18, 2026

Gedeon Richter UK acquires rights to schizophrenia treatment Reagila from Recordati Pharmaceuticals

February 17, 2026